Recent Articles

• Bristol-Myers Squibb to acquire Celgene in deal worth $74 billion
• Pfizer and GlaxoSmithKline to merge consumer healthcare units
• Insight on Daiichi Sankyo’s ROS1/NTRK inhibitor DS-6051 licensing deal with AnHeart Therapeutics
• Boehringer Ingelheim’s ASF COMBAT market launch: East to use Tool in prevention of African swine fever
• 2018 Pharma Deal: Sanofi’s agreement to buy Bioverati @ $10.9 billion
• 2018 Pharma Deal: Novartis’ acquisition of AveXis: $8.1 billion
• US FDA approves Supernus’ sNDA to expand Oxtellar XR label
• Is it always New molecule is first approved in USFDA, instead of the EU approval?
• AbbVie, Pfizer’s non-exlcusive licencing agreement for biosimilar Humira
• Novartis app for opium addicts gets US approval